CR8678A - FORMAS POLIFORMICAS DE HIDROBROMURO ACETATO DE METIL (+)-(s)-ALFA-(-2-CLOROFENIL)-6,7-DIHIDROTIENO [3,2-C]PIRIDINA-5 (4H), HIDROBROMURO DE CLOPIDOGREL - Google Patents

FORMAS POLIFORMICAS DE HIDROBROMURO ACETATO DE METIL (+)-(s)-ALFA-(-2-CLOROFENIL)-6,7-DIHIDROTIENO [3,2-C]PIRIDINA-5 (4H), HIDROBROMURO DE CLOPIDOGREL

Info

Publication number
CR8678A
CR8678A CR8678A CR8678A CR8678A CR 8678 A CR8678 A CR 8678A CR 8678 A CR8678 A CR 8678A CR 8678 A CR8678 A CR 8678A CR 8678 A CR8678 A CR 8678A
Authority
CR
Costa Rica
Prior art keywords
hydrobromide
chlorophenyl
pyridine
dihydrotiene
polyformic
Prior art date
Application number
CR8678A
Other languages
English (en)
Inventor
Alicia Tee Fuay Ng
Keith Richard Lorimer
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CR8678A publication Critical patent/CR8678A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La invencion se refiere a las formas polimorficas B, C y D de acetato de hidrobromuro de metil(+)-(S)-a-(2-clorofenil)-6,7-dihi-drotieno[3,2-C]piridina-5(4H), a las composiciones farmaceuticas que contienen el mismo y al metodo de utilizacion del mismo para inhibir la acumulacion de plaquetas.
CR8678A 2004-04-20 2006-10-09 FORMAS POLIFORMICAS DE HIDROBROMURO ACETATO DE METIL (+)-(s)-ALFA-(-2-CLOROFENIL)-6,7-DIHIDROTIENO [3,2-C]PIRIDINA-5 (4H), HIDROBROMURO DE CLOPIDOGREL CR8678A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56379604P 2004-04-20 2004-04-20

Publications (1)

Publication Number Publication Date
CR8678A true CR8678A (es) 2007-08-28

Family

ID=34966201

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8678A CR8678A (es) 2004-04-20 2006-10-09 FORMAS POLIFORMICAS DE HIDROBROMURO ACETATO DE METIL (+)-(s)-ALFA-(-2-CLOROFENIL)-6,7-DIHIDROTIENO [3,2-C]PIRIDINA-5 (4H), HIDROBROMURO DE CLOPIDOGREL

Country Status (20)

Country Link
US (1) US20070088049A1 (es)
EP (1) EP1756116A1 (es)
JP (1) JP2007533744A (es)
KR (1) KR20070012675A (es)
CN (1) CN1997648A (es)
AU (1) AU2005236034A1 (es)
BR (1) BRPI0509997A (es)
CA (1) CA2562507A1 (es)
CR (1) CR8678A (es)
EA (1) EA010831B1 (es)
EC (1) ECSP066932A (es)
IL (1) IL178680A0 (es)
MA (1) MA28588B1 (es)
MX (1) MXPA06012205A (es)
NO (1) NO20065233L (es)
NZ (1) NZ551371A (es)
TN (1) TNSN06331A1 (es)
UA (1) UA83919C2 (es)
WO (1) WO2005103058A1 (es)
ZA (1) ZA200608569B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
EP1704152A2 (en) * 2004-09-21 2006-09-27 Teva Pharmaceutical Industries Ltd Crystalline clopidogrel hydrobromide and processes for preparation thereof
SI22492A (sl) * 2007-03-08 2008-10-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Polimorfne oblike klopidogrel hidrobromida
UY31531A1 (es) * 2007-12-17 2009-08-03 Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
ATE530172T1 (de) * 2008-02-26 2011-11-15 Lesvi Laboratorios Sl Pharmazeutische formulierungen mit clopidogrel
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2779726B1 (fr) * 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
US7456198B2 (en) * 1999-12-06 2008-11-25 Purdue Pharma L.P. Benzimidazole compounds having nociceptin receptor affinity
CA2470479A1 (en) * 2001-12-18 2003-06-26 Teva Pharmaceutical Industries Ltd. Polymorphs of clopidogrel hydrogensulfate
US7074928B2 (en) * 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
HUP0200438A3 (en) * 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
CZ297472B6 (cs) * 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
GB0321256D0 (en) * 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
GB0325603D0 (en) * 2003-11-03 2003-12-10 Sandoz Ag Organic compounds
EP1713812A1 (en) * 2004-01-13 2006-10-25 Zentiva, a.s. New crystalline forms of clopidogrel hydrobromide and methods of their preparation
AU2005214469A1 (en) * 2004-02-24 2005-09-01 Siegfried Generics International Ag Pharmacologically acceptable salts of clopidogrel

Also Published As

Publication number Publication date
NO20065233L (no) 2006-11-14
ZA200608569B (en) 2007-12-27
EP1756116A1 (en) 2007-02-28
JP2007533744A (ja) 2007-11-22
MXPA06012205A (es) 2007-01-31
US20070088049A1 (en) 2007-04-19
CA2562507A1 (en) 2005-11-03
EA010831B1 (ru) 2008-12-30
MA28588B1 (fr) 2007-05-02
NZ551371A (en) 2010-07-30
IL178680A0 (en) 2007-02-11
KR20070012675A (ko) 2007-01-26
CN1997648A (zh) 2007-07-11
BRPI0509997A (pt) 2007-10-16
UA83919C2 (en) 2008-08-26
WO2005103058A1 (en) 2005-11-03
EA200601921A1 (ru) 2007-02-27
TNSN06331A1 (en) 2008-02-22
AU2005236034A1 (en) 2005-11-03
ECSP066932A (es) 2006-12-20

Similar Documents

Publication Publication Date Title
MA28531B1 (fr) Composition de pyrazolo[3,4-b]pyridine, et son utilisation en tant qu'inhibiteur de pdea4
BG108868A (en) Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds
UY27774A1 (es) Inhibidores de metaloproteinas de triaril-oxi-aril-espiropirimidina-2,4,6-triona
ZA200409862B (en) Benzofused heteroaryl derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
WO2004089951A8 (fr) Derives d’imidazo-pyridine ayant une affinite sur des recepteurs de la melanocortine
CR7333A (es) Forma poliforma de rimonabant, su procedimiento de preparacion y composiciones farmaceuticas que la contienen
EA200600064A1 (ru) Производные тиенопиридона как ингибиторы киназ
WO2005000860A3 (en) Compositions and methods for treatment of disease with acetylated disaccharides
WO2006099217A3 (en) Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
IL154306A0 (en) Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof
PL1692102T3 (pl) Kompozycje i sposoby do wykrywania i leczenia chorób i stanów związanych z receptorami chemokiny
NO20043937L (no) Anvendelse av vitamin D sammensetninger
BR0318449A (pt) processo para fabricação de (+)-(s)-clopidogrel bissulfato forma-i
HK1250679A1 (zh) 口腔用组合物
CR8678A (es) FORMAS POLIFORMICAS DE HIDROBROMURO ACETATO DE METIL (+)-(s)-ALFA-(-2-CLOROFENIL)-6,7-DIHIDROTIENO [3,2-C]PIRIDINA-5 (4H), HIDROBROMURO DE CLOPIDOGREL
DK1620439T3 (da) Hidtil ukendte polymorfer af olanzapinhydrochlorid
CR8651A (es) Sal de clopidogrel y sus formas polimorfas
PA8658001A1 (es) Sulfonamido-macrociclos y sus sales, una composicion farmaceutica que comprende estos compuestos, un metodo de preparacion y el uso de los mismos
ATE513834T1 (de) Verfahren zur herstellung von (s)-(+)- clopidogrelbase und deren salzen
WO2008108742A3 (en) Polymorphic forms of clopidogrel hydrobromide
SG113595A1 (en) New benzo[b]chromeno-naphthyridin-7-one and pyrano[2',3':7,8] quino[2,3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them
DK1392698T3 (da) Fremgangsmåde til fremstilling af 6-aryl-4H-s-triazolo-[3,4-c]thieno[2,3-e]-1,4-diazepiner
DE602006021792D1 (de) Verfahren zur herstellung von olanzapin
PL380849A1 (pl) Krystaliczna postać racemicznego -(2-chlorofenylo)-6,7-dihydrotieno[3,2-c]pirydylo-5(4H)-octanu metylu, sposób jej wytwarzania i zastosowanie
AU2003907110A0 (en) Ornithine Derivatives as Prostaglandin E2 Agonists or Antagonists

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)